Modified-release dosage forms of 5-HT2C agonists useful for weight management
US10463676B2 · kind B2 · utility
0Cited by
78References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 2019 |
| Grant date | Nov 5, 2019 |
| Priority date | — |
| Expiry date | Jan 7, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D223/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for weight management that utilize modified-release dosage forms comprising (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts and crystalline forms thereof. The present invention further relates to (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts, crystalline forms thereof and modified-release dosage forms comprising them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.